Stockwinners Market Radar for August 29, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:12 EDT Amazon to end Honeycode beta service, effective February 29, 2024 - Amazon Honeycode said on its community page, "To our valued customers: After careful consideration, we have made the decision to end the Amazon Honeycode beta service, effective February 29, 2024. New customer sign-ups and account plan upgrades are no longer available. Existing customers will be able to use Honeycode and your Honeycode apps as normal (and add team members to your existing account) until February 29, 2024, when the service will be discontinued. After this date, you will no longer be able to use Honeycode or any of the apps you created in Honeycode. To learn more about this change, and how to download your data, visit the Community Discussions." Reference Link

18:48 EDT Inotiv sells Israeli business to Harlan Holdings - Inotiv announced the completion of the sale of its businesses in Israel. The sale complements Inotiv's site optimization plan for the Research Models and Services segment of the business. The company received cash of approximately $1.2M, including an adjustment for the cash balance at the closing of the sale, a note receivable of approximately $2.5M, including an adjustment for certain reimbursed costs, to be paid in two annual installments on the first and second anniversaries of the closing, and ownership of the Teklad diet manufacturing facility in the U.S., which the company previously leased, as part of the consideration received for this sale. Additionally, the company entered into a five-year supply agreement with the buyer for certain of its diets and bedding. The company entered into a four-year agreement with the buyer, in which the buyer will have exclusive rights to breed and sell all rat and mouse research models of the company within Israel, and the company will receive a 2% royalty during this four-year period. "We are pleased with the outcome of this transaction, as well the progress made to right-size our global footprint," said Robert Leasure, Jr., Inotiv's President and Chief Executive Officer. "With our attractive and competitive profile as a full-service, mid-sized CRO and research model and diet provider, we remain well positioned to maintain strong growth of our businesses. I am also grateful for the contributions made by the Inotiv team as we collectively address both the challenges and opportunities facing our business and industry while delivering a high level of service to our clients."

18:34 EDT Novocure announces data from the randomized phase 3 LUNAR clinical trial - Novocure announced that data from the randomized phase 3 LUNAR clinical trial evaluating the use of Tumor Treating Fields, or TTFields, therapy together with standard systemic therapies for the treatment of metastatic non-small cell lung cancer, NSCLC, following progression on or after platinum-based therapy have been published in The Lancet Oncology. As presented at the 2023 American Society of Clinical Oncology Annual Meeting, the LUNAR trial met its primary endpoint, showing a statistically significant and clinically meaningful 3-month improvement in median overall survival when TTFields therapy was added to physician's choice of immune checkpoint inhibitor, or ICI, or docetaxel. The data demonstrate the efficacy and safety of TTFields therapy in this setting, with no systemic toxicities or new safety signals. In addition, patient-reported data suggest there was no quality-of-life burden associated with adding TTFields therapy to standard therapy. Patients randomized to receive TTFields therapy together with standard therapies demonstrated median OS of 13.2 months compared to 9.9 months in patients treated with standard therapies alone. Patients randomized to receive TTFields therapy and physician's choice ICI demonstrated a median OS of 18.5 months versus a median OS of 10.8 months in patients treated with an ICI alone. Patients randomized to receive TTFields therapy and docetaxel had a positive survival trend with a median OS of 11.1 months vs 8.7 months in patients treated with docetaxel alone. TTFields therapy was well-tolerated with no added systemic toxicities and few grade 3 device-related adverse events. The LUNAR clinical trial data are expected to serve as the basis for a Premarket Approval submission to theFDA in the second half of 2023. Novocure recently completed the LUNAR submission for CE mark.

18:22 EDT Squarespace CEO Casalena sells 30,910 class A shares - In a regulatory filing, Squarespace CEO Anthony Casalena disclosed the sale of 30,910 class A common shares of the company on August 28 at a price of $29.11 per share.

18:07 EDT C5 Acquisition receives noncompliance notice from NYSE over late 10-Q filing - C5 Acquisition Corporation announced that on August 23, 2023, as a result of its inability to timely file with the Securities and Exchange Commission its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023, it received a notice from the New York Stock Exchange stating that the company is not in compliance with Section 802.01E of the NYSE Listed Company Manual. The NYSE notified the company that, under NYSE rules, the company will have six months from August 21, 2023 to file the Form 10-Q with the SEC. The Company can regain compliance with the NYSE listing standards at any time prior to that date by filing its Form 10-Q. If the company fails to file the Form 10-Q within six months from the filing due date, the NYSE may, in its sole discretion, allow the company's securities to trade for up to an additional six months, depending on the specific circumstances. The letter also notes that the NYSE may commence delisting proceedings at any time during the period that is available to complete the filing, if circumstances warrant. As the company reported in its Form 12b-25 filed with the SEC on August 14, 2023, the Form 10-Q could not be filed within the prescribed time period required for smaller reporting companies without unreasonable effort and expense, because the company requires additional time to complete its financial statement preparation and review process. The company continues to work diligently to complete and file the Form 10-Q as soon as practicable.

18:03 EDT Primoris director Schauerman sells 20,000 common shares - In a regulatory filing, Primoris Services director John Schauerman disclosed the sale of 20,000 common shares of the company on August 28 at a price of $34.8001 per share.

17:27 EDT PotlatchDeltic appoints Wayne Wasechek as CFO - PotlatchDeltic (PCH) announced the appointment of Wayne Wasechek as Vice President, CFO, effective immediately. Wasechek has served as Interim Vice President, CFO and Chief Accounting Officer, since April 19. Previously, Wasechek served as PotlatchDeltic's Controller and Principal Accounting Officer since 2018, where he led the accounting and treasury functions. He previously served as Vice President and Assistant Controller of Vail Resorts (MTN) from 2011 to 2018 and as Senior Director of Financial Reporting of Vail Resorts from 2006 to 2011. Wasechek, a certified public accountant, began his career with PricewaterhouseCoopers and holds a degree in business administration with an emphasis in accounting from the University of Colorado, Boulder.

17:15 EDT Huntington Ingalls awarded $154.82M Navy contract modification - Huntington Ingalls was awarded a $154.82M cost-plus-incentive-fee modification to a previously awarded contract for the DDG 1000 Modernization Period execution. Work is expected to be completed by September 2025. FY23 other procurement funds in the amount of $152.52M; and FY23 operation and maintenance funds in the amount of $2.3M, will be obligated at time of award, of which $2.3M will expire at the end of the current fiscal year. Naval Sea Systems Command is the contracting activity.

17:10 EDT Sysco names Greg Bertrand Global Chief Operating Officer, effective September 1 - On August 23, the Board of Directors of Sysco appointed Greg D. Bertrand, currently Sysco's Executive Vice President, U.S. Foodservice Operations, as the Company's Executive Vice President, Global Chief Operating Officer, effective September 1, Bertrand has served as Sysco's Executive Vice President, U.S. Foodservice Operations since July 2018. Reference Link

17:00 EDT Netflix announces new mobile games added in August - "Solve puzzles, build LEGO sets, and fight to the death with four new games this month only on Netflix. SNK Corporation's Samurai Shodown, a reboot of the iconic Japanese game series, is now available exclusively for Netflix members. The title joins three other games that launched earlier this month: LEGO Legacy: Heroes Unboxed by Gameloft, WrestleQuest by Mega Cat Studios, and Cut the Rope Daily by Zeptolab. These games and more than 70 others are included with all Netflix memberships without ads or in-app purchases. Samurai Shodown: Focus your mind, draw your blade, embrace death, anticipate, disarm and attack your opponent to taste sweet victory. .. Available exclusively for Netflix members only on mobile... LEGO Legacy: Heroes Unboxed Captain Redbeard, Princess Storm or Hot Dog Man? Your favorite LEGO minifigures and sets are busting out of the box again! Players can assemble a dream team of minifigures to explore, battle enemies and build sets. Available exclusively for Netflix members...WrestleQuest; Slam your way to the top and draw inspiration from wrestling icons to perfect your signature entrance, moves, and style in this role-playing adventure...Cut the Rope Daily : Solve one new logic puzzle every day to keep your streak alive. Cut ropes and pop balloons to feed a cute green monster, who's craving a candy fix! Om Nom, the world's cutest monster, returns with a renewed craving for candy and a new challenge for the whole Netflix community!" Cut the Rope Daily," wrote the Netflix staff in part, on its blog. Reference Link

16:59 EDT Nasdaq says Sarah Youngwood to succeed Ann Dennison as CFO - Nasdaq (NDAQ) announced the appointment of Sarah Youngwood as Executive Vice President and CFO, effective December 1. Youngwood will succeed Ann Dennison, who has held the role since 2021 and will remain at the company until the end of the year to ensure an orderly transition. Youngwood is an accomplished leader in the financial services industry, having previously served as CFO and Group Executive Board member for UBS Group (UBS), where she held a key role in modernizing the bank's infrastructure and the acquisition of Credit Suisse (CS).

16:47 EDT Epsilon Energy provides update on operations in Pennsylvania and Texas - CEO Jason Stabell states: "In addition to (maintained) quarterly dividend, we would like to provide an update on our operations in Pennsylvania and Texas. We are happy to report that the operator of our upstream assets in the Marcellus recently notified us of near-term drilling plans on our acreage. In late September, drilling will commence on three gross wells (0.39 net). These wells are expected to be on production in the second quarter of 2024. In addition, the operator has begun remedial work on another Auburn area pad to prepare for additional drilling in 2024. We expect this work will result in the drilling of an additional two gross wells in the second half of next year. The remedial work requires the shut-in of approximately 3 MMcf per day of our net production for an estimated 45 days. We expect the shut-in to result in a small net positive adjustment to our full year revenues due to higher forward gas prices in the fourth quarter of this year, with a negligible impact to full year production. However, we estimate third quarter volumes and revenues will be down approximately 5% from our original internal estimates. In Texas, we have reached total measured depth (~2 mile lateral) on our second well in Ector county. Completion operations are scheduled to begin in September on two gross (0.5 net) wells, with first production expected in the fourth quarter. The expected activity will add meaningful production volumes and cash flow in 2024. We look forward to updating you as these plans progress further."

16:43 EDT Gaming and Leisure Properties acquires land in Rockford for $100M - Gaming and Leisure Properties announced that it has acquired the land associated with the Hard Rock Casino development project in Rockford, IL from an affiliate of 815 Entertainment, for $100.0M. Simultaneous with the land acquisition, GLPI entered into a ground lease with 815 Entertainment for a 99-year term. The initial annual rent for the ground lease is $8.0M, subject to fixed 2.0% annual escalation beginning with the lease's first anniversary and for the entirety of its term. In addition to the ground lease, GLPI has also committed to providing up to $150.0M of development funding via a senior secured delayed draw term loan, subject to regulatory review. Any borrowings under the senior secured delayed draw term loan will be subject to an interest rate of 10.0%. The term loan has a draw period of up to 1-year and a maximum outstanding period of up to 6 years. The term loan is prepayable without penalty following the opening of the Hard Rock Casino in Rockford, IL, which is expected in September 2024. The term loan advances will be subject to typical construction lending terms and conditions. In conjunction with the foregoing transactions, GLPI will receive a right of first refusal on the building improvements of the Hard Rock Casino in Rockford, IL if there is a future decision to sell them once completed. CBRE Securities acted as financial advisor to Gaming and Leisure Properties. SMBC Nikko Securities America and Jefferies served as the exclusive financial advisors to 815 Entertainment.

16:35 EDT Beyond Air up 8.5% afterhours at $3.07 following insider buy

16:31 EDT Modine Manufacturing to sell facilities in Temecula and Tampa to Protecall - Modine announced the sale of facilities in Temecula, California, and Tampa, Florida, to Protecall. The sale is expected to be completed by the end of September. The facilities provide aftermarket application services in which HVAC units are coated with anti-corrosion protection. Modine will continue to own and license the spray-applied coatings used in aftermarket applications. Modine currently has more than 100 licensed applicators in the Americas region.

16:30 EDT Beyond Air director buys $673.8K in common stock - n a regulatory filing, Beyond Air disclosed that its director Robert Carey bought 250K shares of common stock on August 28th in a total transaction size of $673.8K.

16:27 EDT Sirius XM CEO buys $1.03M in common stock - In a regulatory filing, Sirius XM disclosed that its CEO Jennifer Witz bought 250K shares of common stock on August 28th in a total transaction size of $1.03M.

16:26 EDT Mr. Cooper CEO Bray sells 21,000 common shares - In a regulatory filing, Mr. Cooper Group CEO Jesse Bray disclosed the sale of 21,000 common shares of the company on August 28 at a price of $55.77 per share.

16:24 EDT AAR Corp. signs two multi-year commercial agreements with Moog - AAR Corp. (AIR) has signed two multi-year commercial agreements with Moog (MOG.A). The agreements are the first steps in a new strategic relationship that allows for potential future expansion of the scope of services provided. Under the first agreement, AAR will distribute Moog products applicable to mature aircraft platforms to customers globally. This new OEM relationship complements AAR's existing product offerings and customer base. Additionally, Moog will benefit from AAR's value added services, which include a model that provides delivery of inventory to the end customer, enabling Moog's effort for further simplification. The second agreement will enable AAR and Moog to perform reciprocal component repair services. AAR's component repair facilities will receive support from Moog on manufactured piece parts and repair capability while Moog will receive components from AAR.

16:16 EDT Telesis Bio names William Kullback as CFO - Telesis Bio has named William Kullback as its CFO, effective immediately. As CFO, Kullback will be responsible for the company's financial planning and analysis, accounting, audit, tax, and treasury functions. With more than twenty-eight years of experience as a CFO, Kullback has held a broad range of financial management and operational roles, primarily in mid-sized to large corporations, including multiple publicly held life-science companies.

16:11 EDT NanoVibronix says PainShield not reimbursable under Medicare, Medicaid - NanoVibronix provided a response to the recently published payment determination by the Centers for Medicare & Medicaid Services regarding the company's PainShield device. On August 21, 2023, CMS announced publication of its Healthcare Common Procedure Coding System Application Summaries, Coding Decisions and Benefit Category & Payment Determinations for the first bi-annual 2023 Non-Drug and Non-Biological Items and Services. As part of its determination, CMS concluded that PainShield does not fall within a Durable Medical Equipment, Prosthetics, Orthotics and Supplies benefit category. As a result of CMS' determination, PainShield is not reimbursable under Medicare and Medicaid at this time. Brian Murphy, Chief Executive Officer of NanoVibronix, Inc., said, "We are working to fully understand the implications of CMS' HCPCS summaries and payment determiniations as it relates to PainShield. Over the coming weeks, we will be developing an action plan to address CMS' concerns and, at the very least, resubmit an application for additional review. We are exploring several options with our legal and technical teams. We continue to believe that PainShield provides an effective therapy for pain management and could greatly benefit many of the more than 150 million patients covered by Medicare and Medicaid insurance2. Despite our disappointment with the recent decision from CMS, we continue to grow the distribution of PainShield in the workers' compensation, personal injury and Veterans' Administration spaces. Medicare and Medicaid beneficiaries represent just one segment of the growing population of patients seeking effective, non-opioid pain management therapies. We remain steadfast in our commitment to fully commercializing PainShield and getting it into the hands of those that could benefit from its use."

15:51 EDT Marriott CEO Capuano sells 20,000 class A shares - In a regulatory filing, Marriott president and CEO Anthony Capuano disclosed the sale of 20,000 class A common shares of the company on August 28 at a price of $202.23 per share.

15:24 EDT Digital Brands Group Inc trading halted, volatility trading pause

13:49 EDT Meta removes thousands of accounts, Pages in China - In a blog post, Meta said it recently took down thousands of accounts and Pages in China that were part of the largest known cross-platform covert influence operation in the world. It targeted more than 50 apps, including Facebook, Instagram, X, YouTube, TikTok, Reddit, Pinterest, Medium, Blogspot, LiveJournal, VKontakte, Vimeo, and dozens of smaller platforms and forums. For the first time, we were able to tie this activity together to confirm it was part of one operation known in the security community as Spamouflage and link it to individuals associated with Chinese law enforcement. In Russia, the company said it blocked thousands of malicious website domains as well as attempts to run fake accounts and Pages on Meta's platforms connected to the Russian operation known as Doppelganger that we first disrupted a year ago. This operation was focused on mimicking websites of mainstream news outlets and government entities to post fake articles aimed at weakening support for Ukraine. It has now expanded beyond initially targeting France, Germany and Ukraine to also include the US and Israel. This is the largest and the most aggressively-persistent Russian-origin operation we've taken down since 2017. Reference Link

12:52 EDT X to allow political advertising on platform, starting in U.S. - X, formerly known as Twitter, stated in a post to its corporate blog: "We have rules in place to help protect the safety and authenticity of conversations on X. During elections, our Civic Integrity Policy provides an extra layer of protection that is applied for a limited period of time before and during an election. We're updating this policy to make sure we strike the right balance between tackling the most harmful types of content-those that could intimidate or deceive people into surrendering their right to participate in a civic process-and not censoring political debate... Building on our commitment to free expression, we are also going to allow political advertising. Starting in the U.S., we'll continue to apply specific policies to paid-for promoted political posts. This will include prohibiting the promotion of false or misleading content, including false or misleading information intended to undermine public confidence in an election, while seeking to preserve free and open political discourse. We'll also provide a global advertising transparency center so that everyone can review political posts being promoted on X, in addition to robust screening processes to ensure only eligible groups and campaigns are able to advertise." Reference Link

12:34 EDT Napco Security expects amended quarterly filings this week - Napco Security said earlier on its Q2 earnings call, "Due to the previously announced need to restate the first, second and third fiscal quarters of fiscal 2023, the company will delay filing its Form 10-K for up to 15 calendar days. We will file the amended 10-Qs as soon as the restatement process is completed with our current expectation being sometime this week." Shares of Napco Security are up 9% to $24.77 in midday trading.

12:05 EDT Apple announces September 12 event where iPhone 15 expected to be unveiled - Apple has announced plans for a September 12 event, with an invite heading "Wonderlust," where the iPhone 15 is expected to be unveiled. Reference Link

12:02 EDT Verizon becomes 'Official 5G Network' of the Carolina Panthers - The Carolina Panthers announced a new partnership with Verizon that will improve the experience for fans at Bank of America Stadium. As the "Official 5G Network of the Carolina Panthers," Verizon will provide connectivity engineered to enhance the fan experience - from helping fans with quick and reliable communications, to catching and sharing all the action on the field. Verizon recently upgraded its 5G Ultra Wideband network inside Bank of America Stadium and will continue with additional upgrades in 2024. As a result, fans in the seats can check scores, watch videos and manage their fantasy teams without worrying about network congestion. Verizon will also work to implement accelerated access technology in the stadium to improve access and ticketing.

12:00 EDT Direxion Daily Semiconductor Bear 3X Shares falls -7.2% - Direxion Daily Semiconductor Bear 3X Shares is down -7.2%, or -74c to $9.59.

12:00 EDT Jackson Financial rises 12.6% - Jackson Financial is up 12.6%, or $4.36 to $38.99.

12:00 EDT Big Lots rises 29.5% - Big Lots is up 29.5%, or $1.85 to $8.13.

11:42 EDT Broadridge exec chairman Daly sells 8,297 common shares - In a regulatory filing, Broadridge Financial executive chairman Richard Daly disclosed the sale of 8,297 common shares of the company on August 28 at a price of $185.4005 per share.

11:08 EDT Marathon, other bitcoin miners jump after court sides with Grayscale over SEC - Shares of Marathon Digital (MARA) and a number of other bitcoin miners are jumping alongside an increase in the price of Bitcoin after the U.S. Court of Appeals for the District of Columbia sided with Grayscale, which maintains its proposed bitcoin exchange-traded product is materially similar to the bitcoin futures exchange-traded products and should have been approved to trade on NYSE Arca, and vacated a prior SEC order that had denied approval of Grayscale's bitcoin fund. Other publicly traded companies in the space include Bit Digital (BTBT), Coinbase (COIN), Core Scientific (CORZ), Greenidge Generation (GREE), MicroStrategy (MSTR), Riot Platforms (riot), Stronghold Digital Mining (SDIG) and TeraWulf (WULF).

10:50 EDT Viveon Health Acquisition, Clearday amend merger agreement - Viveon Health Acquisition and Clearday, announced they have amended the terms of their previously announced Merger Agreement, dated as of April 5, 2023. Pursuant to the terms of the Merger Agreement, a business combination between Viveon and Clearday will be effected through the merger of a wholly owned subsidiary of Viveon with and into Clearday, with Clearday surviving the merger as a wholly owned subsidiary of Viveon. The amendment to the Merger Agreement provides for, among other things, an increase in the merger consideration from $250,000,000 to $500,000,000, payable in shares of Viveon's common stock, that holders of all of Clearday's capital stock at the effective time of the Merger will be entitled to receive a pro rata portion of the earnout shares, and amending the mechanics for appointing a successor Clearday representative.

10:36 EDT Court sides with Grayscale over SEC, vacates order to block bitcoin fund - A three-judge appeals panel for the U.S. Court of Appeals for the District of Columbia wrote in an order dated August 29: "The Securities and Exchange Commission recently approved the trading of two bitcoin futures funds on national exchanges but denied approval of Grayscale's bitcoin fund. Petitioning for review of the Commission's denial order, Grayscale maintains its proposed bitcoin exchange-traded product is materially similar to the bitcoin futures exchange-traded products and should have been approved to trade on NYSE Arca. We agree. The denial of Grayscale's proposal was arbitrary and capricious because the Commission failed to explain its different treatment of similar products. We therefore grant Grayscale's petition and vacate the order." Following news of the appeals court decision, shares of Coinbase are up $9.68, or 13%, to $83.39.

10:31 EDT Coinbase jumps 12% after appeals court overturns bitcoin ETF ruling

10:09 EDT Northwest Biotherapeutics plans to submit MAA for DCVax-L treatment - Northwest Biotherapeutics plans to submit a Marketing Authorization Application in the U.K., to the Medicines and Healthcare Products Regulatory Agency for commercial approval of the Company's DCVax-L treatment for glioblastoma. The Company believes that it has now completed all of the remaining prerequisites for such an application, including certain steps related to implementation of the approved Pediatric Investigation Plan and submission of the required formal notification to the MHRA of the upcoming MAA. As the Company reported in its recent 10-Q filing, the Company is in the final stages of completing the application package itself. The Company anticipates submitting the MAA in approximately the next 30-45 days. The Company plans to request that the MHRA review the MAA under the 150-business day process that the MHRA has established to accelerate the availability of new medicines for patients in the U.K.

10:05 EDT Good Times Restaurants purchases location in Lafayette, Colorado - Bad Daddy's Burger Bar, owned by Good Times Restaurants, announced that on August 28, 2023 it opened its newest Bad Daddy's at Clift Farm in Madison, Alabama. The Company also announced the purchase of the Good Times Burgers & Frozen Custard location on South Boulder Road in Lafayette, Colorado from a franchisee. The Company has reopened the restaurant after a short closure for retraining on systems enhancements including third-party delivery, app-based ordering, and support for the company's recently launched loyalty program, GT Rewards. Additionally, the Company is installing its digital menu package, updating landscaping, and will be lightly refreshing the exterior and interior of the restaurant.

10:00 EDT Sibanye Stillwater falls -10.4% - Sibanye Stillwater is down -10.4%, or -72c to $6.26.

10:00 EDT Jackson Financial rises 9.8% - Jackson Financial is up 9.8%, or $3.39 to $38.02.

10:00 EDT Digital Media Solutions rises 1313.3% - Digital Media Solutions is up 1313.3%, or $3.93 to $4.23.

09:47 EDT Hawaiian Electric falls -5.3% - Hawaiian Electric is down -5.3%, or -74c to $13.22.

09:47 EDT Nio falls -11.0% - Nio is down -11.0%, or -$1.21 to $9.81.

09:47 EDT Jackson Financial rises 9.9% - Jackson Financial is up 9.9%, or $3.42 to $38.05.

09:46 EDT Hitek Global Inc trading resumes

09:42 EDT Brenmiller approved to supply Israel's Wolfson Hospital with electric heat - Brenmiller Energy has received final approval from the Israeli Ministry of Finance to supply electric process heat to Wolfson Hospital. The Israeli Ministry of Finance announced it has approved a budget of up to NIS 14M for Wolfson Hospital to procure TES equipment from Brenmiller. The Israeli Ministry of Finance estimates that the use of electric heat, provided via Brenmiller's bGen ZERO thermal energy storage system, has the potential to save Wolfson Hospital up to $1.3M annually and reduce the hospital's local carbon footprint by 3,900 tons per year. A final agreement between Wolfson Hospital and Brenmiller is under preparation and is expected to be signed by the end of Q4 2023. Subject to negotiation and execution of the definitive Agreement, Brenmiller will deliver its technology and supply heat to Wolfson Hospital at zero up-front cost through an agreement for a seven-year term.

09:36 EDT Knightscope announces a new deployment at an Illinois casino property - Knightscope announces a new deployment at an Illinois casino property utilizing a K5 Autonomous Security Robot. Additionally, the Huntington Park (California) Police Department renewed their contract for the fifth consecutive year for its K5 ASR.

09:35 EDT FedEx Express, Ground and Freight to adjust shipping rates on January 1, 2024 - FedEx Express, FedEx Ground, and FedEx Freight, subsidiaries of FedEx Corp. (NYSE: FDX), will adjust shipping rates on January 1, 2024, the company announced. "FedEx Express shipping rates will increase by an average of 5.9% for U.S. domestic, U.S. export, and U.S. import services. FedEx Ground and FedEx Home Delivery shipping rates will increase by an average of 5.9%. FedEx Ground Economy shipping rates will also increase. FedEx Freight shipping rates will increase by an average of 5.9%-6.9% dependent on the customer's transportation rate scale. This change applies to shipments within the U.S. (including Alaska, Hawaii, Puerto Rico, and the U.S. Virgin Islands) and between the contiguous U.S. and Canada. The average annual rate increases are one percentage point lower than last year's general rate increase. The price adjustments reflect incremental costs associated with the current operating environment, while enabling FedEx to continue investing in service enhancement, fleet maintenance, technology innovations, and other areas to serve customers more effectively and efficiently," the company stated. Reference Link

09:33 EDT Inspira Technologies signs agreement expansion with Innovimed - Inspira Technologies has signed a further Service Agreement to supplement its previously announced Strategic Agreement with Innovimed for planned clinical trials of the INSPIRA ART medical devices. The extended agreement covers any European country. The company to-date have signed summary distribution agreements with Innovimed in Poland, Czech Republic and Slovakia, subject to completion of product development and regulatory approval, potentially generating over $130 million in revenues for the Company over seven years.

09:32 EDT Co-Diagnostics appoints Ivory Chang as Chief Regulatory Affairs Officer - Co-Diagnostics announced that it welcomes Ivory Chang as the company's Chief Regulatory Affairs Officer. "Ms. Chang's in-depth regulatory affairs experience has included time spent with several notable names in the diagnostics industry, including Roche, Boston Scientific, BD Biosciences, Cepheid, Thermo Fisher Scientific, and more," the company stated.

09:26 EDT Amazon acquires startup Fig, terms not disclosed - Fig co-founder and CEO Brendan Falk wrote in a Monday blog post, "I am thrilled to announce that the Fig team will be joining Amazon Web Services and Amazon has acquired Fig's technology! Fig and AWS share a passion for improved developer tools and services. By combining Fig's expertise with AWS' long-term orientation and track record of delivering customer-centric products, we see an opportunity to enhance the developer experience. AWS believes that generative AI represents a major technological shift to transform the way its customers build, and we are beyond excited to be a part of that larger vision...Existing users will continue to be able to use Fig and will receive ongoing support. What's more, we are now making all the paid Fig Team features completely free. New users will not be able to sign up for Fig's products right now while we focus on optimizing them for existing customers and addressing some needs identified to integrate Fig with AWS. If you're interested in staying up-to-date on our work with AWS, we will release a signup link in the coming weeks!" Reference Link

09:24 EDT Prologis clears redemption requests in U.S. and European funds, commits $500M - Prologis has cleared all redemption requests as of June 30 for its two major strategic capital funds, Prologis European Logistics Fund - PELF - and Prologis U.S. Logistics Fund - USLF -. The company also announced an additional commitment of $500M to the funds, EUR250M in PELF and $250M in USLF.

09:18 EDT Varonis opens UK data center to support SaaS customers - Varonis Systems announced its first data center in the U.K. to support customers moving to Varonis' SaaS offering. The new data center, located in London, will help Varonis customers demonstrate compliance with national data protection laws and enable them to leverage Varonis' world-class automation, visibility, and support. The new data center will help Varonis meet growing demand in the U.K., where organizations must follow data protection principles under the Data Protection Act that control how organizations, businesses, and the government use personal information.

09:13 EDT CareCloud announces integration of talkEHR platform at Sympathy Health Clinic - CareCloud announced the successful integration of its talkEHR platform at Sympathy Health Clinic in Las Vegas. This integration stands as a leap forward in enhancing the clinic's patient care and practice management capabilities. The comprehensive talkEHR offerings seamlessly integrated into Sympathy Health encompass cutting-edge functionalities, including electronic health records, practice management, telehealth, electronic prescription, and electronic claims. The core objective of this integration is to streamline the day-to-day workflows of healthcare providers while simultaneously elevating the overall patient experience. The decision of Sympathy Health Clinic to transition to CareCloud's talkEHR stems from their requirement for a comprehensive solution that includes telehealth capabilities.

09:12 EDT Camber, JV partners introduce portfolio of detection systems to reduce wildfires - Camber Energy and its joint venture partners officially introduce for use by utilities around the world an expanded portfolio of fully developed, patent pending, ready-for-market proprietary Electrical Transmission and Distribution Open Conductor Detection Systems designed to detect unsafe and hazardous conditions for transmission lines and distribution lines of any length and any voltage. The systems are designed to immediately identify when a conductor breaks or opens and to instantly de-energize the appropriate source of power, whether it be from a transmission line or distribution line. This novel approach affords our technology a unique advantage in detecting open conductors before they make contact with the ground.

09:10 EDT Celularity enters Research Collaboration Services Agreement with Regeneron - Celularity (CELU) announced a multi-year Research Collaboration Services Agreement with Regeneron Pharmaceuticals (REGN) to support the research of Regeneron's allogeneic cell therapy candidates. The agreement's initial focus is the research on a targeted allogeneic gamma delta chimeric antigen receptor T-cell therapy owned by Regeneron designed to enhance proliferation and potency against solid tumors. "The agreement with Regeneron announced today is an important milestone for Celularity that recognizes our expertise in the research of cellular therapies, including the engineering of CAR-T cells. We believe that this relationship paves the way for future industry collaborations leveraging our world class cell therapy facilities and capabilities," said Robert Hariri, M.D., Ph.D., Celularity's CEO, Chairman and Founder. "We have long admired the exceptional scientific legacy at Regeneron and welcome the opportunity to collaborate with a world leader in innovative medicines."

09:08 EDT Dolphin Entertainment's 42West named Agency of Record for Dark Taverns - Dolphin Entertainment celebrates the collaboration between its subsidiary, 42West, and the eagerly anticipated massively multiplayer online role playing game, Dark Taverns. This partnership emphasizes 42West's steadfast dedication to elevating the world of gaming and enhances its longstanding commitment to pop culture, consumer products, and technology.

09:07 EDT LogicMark signs manufacturing agreement with AQS - LogicMark announced an agreement with All Quality and Services, AQS, to engineer and manufacture new hardware devices, the first product of which is scheduled to launch next year. "Having an additional contract manufacturer based in the U.S. helps us diversify our risk and minimize supply chain disruptions, ensuring our customers have the products they need. Our customers are also requesting products that are 'Made in USA'. With existing tariffs on imported products, manufacturing in the USA is now more competitive, which allows us to increase the number of cost effective customer solutions. We look forward to partnering with AQS to help us introduce new products into the marketplace, which will supplement life saving products already in our pipeline expected for launch in 2023 and 2024," said LogicMark CEO, Chia-Lin Simmons.

09:06 EDT Getty Images announced as official photographer for 2024 Spring/Summer NYFW - Getty Images has been named as the Official Photographer for the 2024 Spring/Summer Season of IMG's New York Fashion Week, NYFW: The Shows. As the Official Photographer, Getty Images' award-winning entertainment photographers will be delivering high-quality imagery throughout New York Fashion Week in New York City, all to be distributed exclusively through gettyimages.com. "Each year, New York Fashion Week continues to be a premier event, providing leading designers from around the world with a global platform to showcase their collections and trends for the upcoming season," said Getty Images VP of Global Entertainment Kirstin Benson. "We are thrilled to partner with IMG once again to deliver unrivalled, compelling and differentiated content -- from all runway shows, fashion and behind the scenes moments -- that our global customer base won't find anywhere else."

09:04 EDT Shuttle Pharmaceuticals' HDAC6 inhibitor shows immune response stimulation - Shuttle Pharmaceuticals announced the publication of a manuscript reporting on the ability of Shuttle's lead Histone deacetylase 6 - HDAC6 - inhibitor drug candidate - SP-2-225 - to stimulate the innate immune system following radiation therapy. The manuscript was published in Molecular Cancer Therapeutics, a scientific journal affiliated with the American Association for Cancer Research. The report highlights to the scientific and financial community how our novel selective inhibitor (SP-2-225) is able to target the HDAC6 function in tumors to inhibit tumor growth and enhance the M1/M2 ratio of infiltrating macrophages within tumors as a combination therapy with RT," commented Anatoly Dritschilo, CEO. "These observations support a strategy to advance the use of selective HDAC6 inhibitors to improve antitumor immune responses and prevent tumor relapse post-radiation therapy." RT is a curative cancer treatment modality that imparts damage to cellular DNA, induces immunogenic cell death, and activates antitumor immunity. Acute proinflammatory responses mediated by anticancer M1 macrophages are observed in the immediate aftermath following RT. However, after a few days, these M1 macrophages are converted to anti-inflammatory and pro-cancer M2 phenotype, leading to cancer resistance and underlying potential tumor relapse.

09:02 EDT Backblaze announces expanded partnership with Qencode - Backblaze announced an expanded partnership with Qencode, a media services platform that enables users to build powerful video solutions. The expanded partnership embeds the Backblaze Partner API within the Qencode platform, making it frictionless for users to add cloud storage to their media production workflows.

08:42 EDT Nio CEO says 'confident' in delivery volume guidance provided - Nio CEO William Li said on the company's Q2 call, according to a transcript: "So starting from June and July and August, we have taken a more active manner in improving our sales capabilities. And with that, we hope that the company will be able to support the new orders of 30,000 units per month that will be contributed by our sales network as well as the personnel increase. So that by the end of September, we will be able to realize that target. Of course, it takes time for us to really train the personnel and also to find the locations. So we will have that initial capability ready by the end of September, and then the real effect will kick in from October. That is our existing plan for the improvement. This is also why starting July and August, we've been taking some active measures and actions in expanding our sales network and touch points, especially in lower-tier cities where we don't have a full-fledged facilities or stores, we hope to really secure and hire experience and season salespersons who have their networks and user bases already to help us with the sales test. And regarding your second question, in July, we have delivered more than 20,000 vehicles. And as shown by our guidance, our delivery volume in August and September are lower than that in July. This is mainly because by the end of July, we have announced the adjustment to our Power Swap user benefits before users enjoy or are entitled to or swaps per month. But starting from August 1, all the new orders are not entitled to free swaps anymore. This also helped us to pull ahead some orders or users with strong demand for Power Swap in July, and this has also affected the delivery volume in July. In terms of the August, we believe that it will take some time for the order momentum and intake to be back to the normal track. But in the meantime, in August, we've also witnessed a new high of the numbers of test drives and leads. Average speaking, during the weekends, we have more than 10,000 test drives. This represents a significant growth from the past month. And in the meantime, we also understand that it will take some time for the test drive to be truly converted into orders and we will wait for that. But over speaking, we are very confident in stabilizing the order intake as well as the delivery volume. In the meantime, we also need to understand the external challenges, especially the challenges and the pressure from the macroeconomic environment. So our fair cost and guidance have also considered that those external factors. But overall speaking, we are confident in the delivery volumes we provided."

08:39 EDT AYRO awarded patent for vehicle seat design - AYRO has been issued U.S. Patent No. D996076 from the U.S. Patent and Trademark Office for the "vehicle seat" of the 2023 AYRO Vanish . The awarded design patent is for the ornamental design of a new exoframe seat onto which customizable damped and covered bolsters may be fastened to improve ride comfort and diminish driver fatigue.

08:38 EDT Evaxion Biotech appoints Kanstrup as CEO - Evaxion Biotech (EVAX) announced: Evaxion has hired a new Chief Executive Officer, CEO, to accelerate the strategic development and execution of the vast business opportunities at hand after having matured the Company's AI platforms over the past 15 years. Christian Kanstrup has accepted the role as CEO of Evaxion. Kanstrup has held several senior leadership positions at Novo Nordisk (NVO), including Head of Biopharma Operations.

08:37 EDT SP Plus enters parking, shuttle operations contract at Eppley Airport - SP+ Corporation announced its five-year contract for management of all public and employee parking facilities, and public and employee shuttle service at Eppley Airport, in Omaha, Nebraska.

08:35 EDT Neurocrine's Ingrezza shows improvement in tardive dyskinesia study - Neurocrine presented findings from a data analysis of KINECT-4 demonstrating a comparable pattern of improvement over time of clinician-rated tardive dyskinesia - TD - severity and awareness/distress and patient-reported TD impact. KINECT-4 is a Phase 3 study in which 163 participants with moderate to severe TD and underlying schizophrenia, schizoaffective disorder or mood disorder received 48 weeks of open-label treatment with once-daily Ingrezza followed by a four-week washout. The data was presented at the MDS International Congress of Parkinson's Disease and Movement Disorders in Copenhagen, Denmark. The data analysis evaluated the use of Ingrezza for the treatment of TD among all 167 patients with either schizophrenia or mood disorders enrolled over the course of the Phase 3, open-label, long-term study. On average, the analysis suggested that clinician-rated TD severity decreased with one-capsule, once-daily Ingrezza treatment over the course of the 48-week study. Researchers concluded that the use of AIMS and TDIS in evaluating symptom improvement during treatment may give a more complementary understanding regarding the patient's TD experience.

08:35 EDT Grom Social Enterprises secures over $1.2M in new production assignments - Top Draw Animation, TDA, a division of Grom Social Enterprises, announced that it will begin work later this month on new assignments for a combined value of $1.259MM. The new projects add to the $2.2MM of value from remaining contracted assignments already in progress as of June 30, 2023. The values and assignments were confirmed today by Top Draw Animation's Executive Vice President, Jared Wolfson. "Top Draw Animation continues to deliver best-in-class animation production to audiences around the world," explains Wolfson. "The passion, creativity and commitment to excellence coming from the dedicated teams at our Manila-based headquarters continue to drive studio growth."

08:34 EDT Cemtrex receives $1.5M upgrade order for Vicon Valerus Systm - Cemtrex has received a $1.5 million order through its Vicon Industries subsidiary for a large correctional facility, and current end-customer, in Maryland to upgrade its security technology system with new Valerus software and hardware.

08:32 EDT ClearSign awarded Phase 2 grant from Department of Energy - ClearSign Technologies announces that the company was awarded a Phase 2 government grant through the Small Business Innovative Research program with the Department of Energy. This project is being funded by a government grant through the SBIR program with the DOE to support scientific innovation in clean energy development and climate solutions. This second grant award follows the successful development and demonstration of a ClearSign Core Ultra Low NOx burner fueled with 100% hydrogen, which was funded by the Phase I grant amount of $250,000. This Phase 2 government grant award was for the maximum amount of $1.65M for a two-year duration, which the company intends to apply to the development of ultra-low NOx hydrogen burner technologies.

08:29 EDT OceanPal becomes strategic partner in chemical tanker newbuildings - OceanPal agreed to become a strategic partner and invest in a Norwegian entity, RFSea Infrastructure II AS, that will construct, at Wuhu Shipyard, under two separate newbuilding contracts, two 6,600 dwt methanol-ready, stainless steel chemical tankers with expected deliveries during the fourth quarter of 2025 and the first quarter of 2026, respectively. The transaction remains subject to the satisfaction of customary closing conditions. The Company is partnering with a private London-based alternative investment and commercial management firm focusing on the maritime industry and other partners and investors. Fearnley Securities AS acted as the project arranger.

08:21 EDT Foremost Lithium undertakes extensive exploration program - Foremost Lithium Resource & Technology has undertaken an extensive summer exploration program on its "Lithium Lane Properties", near the historic mining center of Snow Lake, Manitoba. Dahrouge Geological Consulting is conducting a large-scale surface exploration program on Foremost's four Lithium Lane properties for Lithium Cesium Tantalum pegmatites which includes: Targeted geochemical sampling and geological mapping; Prospecting and rock sampling over priority target areasl MMI-soil or till sampling of target areas lacking outcrop; Detailed geological mapping in highly prospective zones, and data captured using ESRI Field Maps. DGC has applied its established targeting methodology to Foremost's extensive geological database, integrating historical and recent exploration records to highlight high-priority targets. The program's focus includes properties that are either under-explored or have good potential for discovering additional LCT pegmatites. Jason Barnard, Foremost President, and CEO comments "Preliminary assessment on our Lithium Lane Properties provided from Dahrouge are encouraging for discovery of further LCT pegmatites. The properties are certainly not short on potential targets, and we look forward for results of this exploration program to help delineate drill targets on all our Lithium Lane Properties".

08:18 EDT Six Flags launching virtual assistant powered by Google Cloud AI - Six Flags (SIX) is working with Alphabet's (GOOG) Google Cloud to enhance visitor experiences and optimize business operations. This collaboration will involve using Google Cloud's Vertex AI Conversation and other services to accelerate digital transformation at Six Flags, including the introduction of a virtual assistant powered by generative AI. Six Flags will also apply Google Cloud's capabilities in AI, analytics, and infrastructure for operations, personalization, and customer experiences across Six Flags' portfolio of parks. Six Flags' virtual assistant, powered by Google Cloud's Vertex AI Conversation, will be available later this year on the revamped Six Flags mobile app and park websites. On the app, the virtual assistant will guide visitors in planning their day at the park with personalized recommendations. On the website, it will answer customer queries, reducing the need for interaction with live agents.

08:18 EDT Nogin's Intelligent Commerce technology chosen by Rumpl - Nogin announced that Rumpl, the category leader in technical blankets, has chosen Nogin's Intelligent Commerce technology and services to grow its direct-to-consumer business. Nogin's enterprise-class technology and deep ecommerce expertise will drive accelerated growth for Rumpl as it continues to redefine the category of blankets and technical comfort products. "We are thrilled to partner with Rumpl in their journey to elevate the outdoor experience for adventurers around the world," said Shahriyar Rahmati, COO and CFO at Nogin. "With Nogin's Intelligent Commerce technology and ecommerce expertise, we have the unique capabilities to drive Rumpl's D2C expansion, leveraging AI-driven strategies to enhance customer engagement and maximize growth. Together, we can cement Rumpl's position as a pioneering leader within the realm of technical blankets and outdoor products."

08:15 EDT Teledyne in $31M contract with Kongsberg Defence for C-UAS systems for Ukraine - Teledyne FLIR Defense, part of Teledyne Technologies has signed a contract with Kongsberg Defence & Aerospace, Norway, valued at roughly $31M to provide its Cerberus XL mobile counter-unmanned aerial system UAS as part of a total C-UAS solution for Ukraine. The agreement includes delivery of the surveillance platforms as well as software, spares, support and training. "Teledyne FLIR is proud to partner with Kongsberg in delivering our next-generation Cerberus XL as part of a complete and robust system to protect Ukraine's warfighters," said Dr. JihFen Lei, Executive VP of Teledyne FLIR Defense. Kongsberg recently signed an agreement with the International Fund for Ukraine to deliver counter-drone systems that will be donated to the war-torn nation. The IFU was established by the UK and international partners to identify and procure critical capabilities and deliver them quickly to Ukraine. Norway and the UK are among many nations that have contributed to the fund.

08:15 EDT Onfolio launches 506(c) Series A Preferred Share Offering - Onfolio Holdings is offering up to 400,000 shares of its Series A Preferred Shares at $25 per share for an aggregate offering amount of $10 million. The shares will be offered to accredited investors only pursuant to Regulation D, Rule 506(c) under the Securities Act of 1933, as amended. Although general solicitation is permitted under Rule 506(c) offerings, purchasers must be accredited investors and meet certain Securities and Exchange Commission verification requirements for validation of their "accredited investor" status. The Company intends to use the net proceeds from this offering for acquisitions purposes and general corporate purposes.

08:12 EDT Immucell announces submission of CMC Technical Section to FDA - ImmuCell Corporation announced that it recently submitted the Chemistry, Manufacturing and Controls, CMC, Technical Section for Re-Tain to the FDA. On August 10, 2023, the Company issued a disclosure stating that it anticipated making this submission "shortly" after the filing of its Quarterly Report on Form 10-Q. The Company is now confirming that this objective was achieved. "For the benefit of clarity, we want to inform investors that this important step in the regulatory process was taken on August 18, 2023," commented Michael F. Brigham, President and CEO of ImmuCell. "This kind of submission is subject to a six-month review by the FDA, and we are excited about the opportunity ahead."

08:10 EDT Erasca doses first patient in SEACRAFT-1 Phase 1b trial - Erasca announced dosing of the first patient in the SEACRAFT-1 Phase 1b trial evaluating pan-RAF inhibitor naporafenib in combination with MEK inhibitor trametinib in patients with RAS Q61X solid tumors. "Naporafenib has been dosed in over 500 patients to date, establishing its safety, tolerability, and preliminary proof-of-concept in multiple indications," said Jonathan E. Lim, M.D., Erasca's chairman, CEO, and co-founder. "SEACRAFT-1 will explore the potential of naporafenib plus trametinib in patients with RAS Q61X solid tumors, which affects over 150,000 patients in the United States and Europe. This tissue agnostic approach is based on the encouraging anti-tumor activity generated by Novartis in patients with NRAS Q61X melanoma or KRAS Q61X non-small cell lung cancer. We look forward to sharing signal-seeking efficacy data in relevant tumor types from SEACRAFT-1 between the second and fourth quarters of 2024. In addition, we are on track to initiate SEACRAFT-2, a pivotal Phase 3 trial to evaluate naporafenib plus trametinib in patients with NRAS-mutant melanoma, in the first half of 2024."

08:10 EDT MSCI teams with Google Cloud to accelerate generative AI solutions - MSCI (MSCI) announced an expansion of its partnership with Google (GOOG) Cloud to accelerate the development of generative AI (gen AI) solutions for the investment industry. Powered by Google Cloud's gen AI platform Vertex AI and climate technology, including BigQuery Geospatial and Earth Engine, the solutions will help MSCI clients better manage portfolio risks and opportunities and make informed investment decisions. The partnership will focus on three key areas: Risk Signals: MSCI will combine its proprietary data and analytics with Google Cloud's gen AI solutions to provide an overview of portfolio and enterprise level risk designed to significantly reduce the time clients need to analyze and arrive at actionable insights. This solution will help portfolio and risk managers more easily synthesize and rapidly act on significant volumes of risk signals from their portfolios, while also fostering greater collaboration between risk and portfolio management teams to build more resilient portfolios.

08:08 EDT SAP appoints Gina Vargiu-Breuer as new Chief People Officer - SAP has appointed Gina Vargiu-Breuer to the Executive Board of SAP as Chief People Officer and labor director, effective from February 1, 2024. She will succeed Sabine Bendiek, who will be leaving the company by her own request on December 31, 2023. Vargiu-Breuer joins from Siemens Energy, where she has been serving as the Global Head of HR since the separation from Siemens in late 2019. Prior to her time at Siemens Energy, Vargiu-Breuer worked at Siemens, where she held various operational and strategic HR roles, including positions in Asia, the United States and the United Arab Emirates. Vargiu-Breuer has been appointed to the Executive Board for a term of three years and will be based at the SAP headquarters in Walldorf, Germany. The role of Chief Operating Officer - previously also under Sabine Bendiek's responsibility - will be assumed by Chief Strategy Officer Sebastian Steinhaeuser starting January 1, 2024.

08:07 EDT Axcella Health granted patent for Long COVID Fatigue treatment - Axcella Therapeutics announced that the U.S. Patent and Trademark Office USPTO has granted U.S. Patent No. 11,737,999 with claims covering methods of use of Candidate AXA1125, for treating a subject having post-acute sequelae of COVID-19 , a/k/a Long COVID, particularly fatigue. The patent was issued on August 29, 2023, with anticipated expiration in 2042. "Today's issuance expands our global patent portfolio and Axcella's protection of its lead candidate, AXA1125," said Paul F. Fehlner, J.D., Ph.D., Senior Vice President, Chief Legal Officer of Axcella. "These patents and our entire portfolio are fully owned by Axcella." AXA1125 is a novel composition of EMMs designed to simultaneously support metabolic, inflammatory and fibrotic pathways associated with fatigue. Axcella was previously granted patents related to AXA1125 with claims covering methods of use and compositions. In particular, Patents Nos. 10,201,513, 10,471,034, 11,129,804, and 11,602,511 cover the AXA1125 compositions, including pharmaceuticals and nutritional supplements. These previously granted patents have an anticipated expiration date in 2037. "In addition to further strengthening Axcella's global intellectual property position regarding its proprietary composition of amino acids in AXA1125, today's patent issuance further validates AXA1125's formulation and its tie to treating PASC or Long COVID, explicitly symptoms of fatigue," said Bill Hinshaw, President and Chief Executive Officer of Axcella. "We are pleased to have this additional designation as we pursue options to bring our investigational product forward for the benefit of the millions of people who continue to suffer from Long COVID Fatigue. The understanding of the disease continues to advance and show the importance of mitochondrial function and how a mitochondrial activator like AXA1125 has the potential to impact the issues these patients face."

08:05 EDT Ginkgo Bioworks, Google Cloud announce five-year AI partnership - Ginkgo Bioworks (DNA) and Google Cloud (GOOG, GOOGL) announced a five-year strategic cloud and AI partnership, intended to enable Ginkgo to develop and deploy AI tools for biology and biosecurity. Under the strategic partnership, Ginkgo will work to develop new, state-of-the-art large language models running on Google Cloud's Vertex AI platform across genomics, protein function, and synthetic biology, helping Ginkgo's customers accelerate innovation and discovery in fields as diverse as drug discovery, agriculture, industrial manufacturing, and biosecurity. Ginkgo intends to make Google Cloud its primary cloud services provider, significantly increasing its next-generation cloud computing resources, positioning Ginkgo and its customers well as the need for cloud computing expands. In addition, Google Cloud will provide funding to help Ginkgo achieve certain milestones over the next three years. The commitment underscores Google Cloud's support in advancing foundation models in the life sciences sector and selection of Ginkgo as its key partner in the development of this ecosystem.

08:05 EDT Ford expands charging solutions for commercial customers - Ford Pro, the commercial division within Ford, revealed new charging hardware added to its suite of end-to-end solutions to help make it easier for commercial customers to transition their fleets to electric. The new Series 2 AC Charging Station 80 amp and expanded DC Fast Charger options are designed for commercial vehicle use and packed with new features. Coupled with Ford Pro's charging management software, the company provides a fully integrated solution that simplifies EV charging for both Ford and non-Ford electric vehicles.

08:04 EDT Globalstar CEO David Kagan retires, Paul Jacobs succeeds - Globalstar (GSAT) announced that Paul Jacobs, founder and CEO of XCOM Labs, has been appointed CEO of Globalstar, effective immediately. Jacobs has also been appointed to Globalstar's board of directors. He succeeds David Kagan, who will retire as Globalstar's CEO. In conjunction with Jacobs' appointment, Globalstar has also entered into a strategic perpetual licensing agreement for exclusive access to certain key XCOM technologies and personnel. The license covers a number of XCOM's novel technologies for wireless spectrum innovations, including XCOMP, XCOM's commercially available coordinated multipoint radio system. XCOMP delivers substantial capacity gains and other benefits in dense, complex, challenging wireless environments in sub 7 GHz spectrum. Globalstar also gains exclusive access to XCOM's peer-to-peer connectivity technologies that could have applications across cellular and satellite devices.

08:03 EDT ICU Medical granted FDA Clearance for Plum Duo pump with LifeShield software - ICU Medical has received 510(k) regulatory clearance from the FDA for the Plum Duo infusion pump with LifeShield infusion safety software. The Plum Duo pump and LifeShield software will be available to customers in the U.S. in early 2024. The Plum Duo pump features a color touch screen with two channels capable of delivering up to four compatible IV medications. LifeShield infusion safety software is a unified cloud-based software suite that provides new tools for drug library management.

07:58 EDT William Penn board authorizes stock repurchase program up to 10% of stock - William Penn Bancorporation announced that the Company's Board of Directors has authorized a new stock repurchase program to acquire up to 1,138,470 shares, or approximately 10.0%, of the Company's currently issued and outstanding common stock. The new stock repurchase program was authorized following the completion of the Company's previously announced stock repurchase program on August 28, 2023. The new stock repurchase program was adopted following the Company's consultation with the Federal Reserve Bank of Philadelphia.

07:51 EDT Biden unveils first 10 drugs subject to Medicare price negotiation - The Biden administration announced the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare as part of the Inflation Reduction Act. The drugs subject to the initial talks this year are Eliquis, made by Bristol-Myers Squibb (BMY), Jardiance, made by Eli Lilly (LLY), Xarelto, made by Johnson & Johnson (JNJ), Januvia, made by Merck (MRK), Farxiga, made by AstraZeneca (AZN), Entresto, made by Novartis (NVS), Enbrel, made by Amgen (AMGN), Imbruvica, made by AbbVie (ABBV), Stelara, made by Johnson & Johnson, and Fiasp and NovoLog insulins made by Novo Nordisk (NVO).

07:41 EDT ARway.ai CEO Evan Gappelberg buys 18K shares of company - ARway.ai announces that the CEO Evan Gappelberg has purchased 18,000 shares in open market buys on August 24th & 25th with an avg purchase price of $0.45 or C$0 .61. Evan Gappelberg CEO of ARway Comments "It's clear to me that our technology is very valuable and being well received by our customers which include mall operators, rental car companies, museums, stadiums, hospitals and developers. It's also clear to me that our share price is very low and not reflective of the upside potential that I see with our augmented reality platform." He continues "We are only just entering the first inning of a nine inning game. I believe that we have the technology and team to be a leader in the indoor positioning and navigation market which is estimated to be worth $5.9 billion today growing at a CAGR of 42.6% and is expected to reach $102billion by the end of this decade, according to Maximizer market Research. That's why I'm buying stock and adding to my position here."

07:39 EDT Dundee receives court decision on permitting process for Loma Larga - Dundee Precious Metals announced that a decision on the appeal of the Constitutional Protective Action filed against the Ministry of Environment, Water and Ecological Transition was delivered by the Provincial Court of Azuay in Ecuador. Based on the Company's preliminary analysis, the decision reaffirmed DPM's mining concessions for the Loma Larga project, and clarified that free, prior and informed consultation of certain local indigenous populations must be carried out by the state, which the Company had already planned as part of its development of the project. The decision also held that environmental consultation with communities in the project's area of influence and certain additional reports on the impact of the project on water resources and the Quimsacocha National Recreation Area would need to be provided by the MAATE to the Court prior to advancing the project to the exploitation phase. "As we assess the court's decision, we remain committed to the highest applicable standards for environmental protection and stakeholder engagement in-line with International Finance Corporation standards," said David Rae, President and Chief Executive Officer. "DPM will be engaging with the government to outline the next steps for the consultation activities and, based on the extensive environmental work completed to date, we will work with MAATE to provide any additional detail as quickly as possible. We will continue to take a disciplined approach to future investment and advancement of the Loma Larga project based on the receipt of key milestones and the overall operating environment in country."

07:37 EDT Red Cat announces Senator Mitt Romeny visited Teal Drones headquarters - Red Cat announces that Utah Sen. Mitt Romney recently toured the Salt Lake City headquarters of Red Cat subsidiary Teal Drones. The visit, which took place on Aug. 22, was designed to educate Sen. Romney on Teal's operations, specifically its factory that was purpose-built to meet the growing demand for U.S.-made drones. Sen. Romney is a co-sponsor of the American Security Drone Act of 2023, which aims to strengthen U.S. drone manufacturing for national security purposes by prohibiting federal agencies from purchasing drones made by Chinese government-linked companies. "We're grateful for Sen. Romney's interest in our company and his ongoing support for the U.S. drone industry," said George Matus, Teal founder and CEO. "The American Security Drone Act, if passed, will lead to further investment in American UAS, accelerating our domestic industry's ability to close the gap with China and build a strategic deterrence to future conflict."

07:36 EDT Magna commits to achieve net-zero by 2050 - Magna is taking a significant step forward in its commitment to sustainability and environmental stewardship by submitting net-zero emissions targets for validation by the Science Based Targets initiative, the widely-accepted benchmark for decarbonization targets in line with the Paris Climate Agreement. The company's goal is to achieve net-zero emissions status by 2050, and meet its near-term Scope 1, 2 and 3 targets by 2030. "Magna has focused on creating a better world of mobility, and the company's pursuit of net-zero emissions reflects this commitment," said Magna CEO Swamy Kotagiri. "To reach this ambitious target, we are addressing not only the emissions we produce within our own facilities but also those of our entire supply chain, while supporting the industry move to low-carbon mobility technology. By embracing sustainable practices, shifting to renewable energy sources, making our manufacturing processes more efficient and partnering with our customers in the transition to electric vehicles, we want to make a positive impact on the planet and future generations." Magna's pursuit of net-zero emissions will involve several interim steps, including transitioning to 100% renewable electricity use in the company's European operations by 2025 and globally by 2030. Magna's net-zero strategy includes a near-term commitment to reduce approximately 42% of the company's scope 1 and 2 emissions, and approximately 25% of its scope 3 emissions, each by 2030.

07:35 EDT FTI Consulting partners with Agiloft - FTI Consulting announced that the firm's Technology segment has entered into a partnership with Agiloft, a global no-code contract lifecycle management solution provider. FTI Technology's Corporate Legal Operations practice will work strategically with Agiloft to help clients improve return on investment and accelerate adoption for their CLM implementations. Wafik Guirgis, a Senior Managing Director and global Co-Leader of FTI Technology's Corporate Legal Operations practice, said "Selection, preparation and implementation require tremendous investment of time, people and other resources, as well as nuanced change management. To quickly achieve results from a CLM solution investment, organizations need a clear understanding of contracting operations and a solution partner that has demonstrable success in reliably addressing challenges. By partnering with leading solution providers like Agiloft, we can better assist our clients in obtaining their transformation goals, like speed-to-market and other critical commercial efficiency objectives."

07:33 EDT Entergy subsidiary receives favorable FERC ruling in refund dispute - Entergy subsidiary System Energy Resources, or SERI, announced that the Federal Energy Regulatory Commission resolved a long-standing litigation matter related to uncertain tax positions taken by SERI, by denying a request for SERI to pay additional refunds to customers. The FERC ruling also ordered SERI to recalculate the value of overpayments on sale-leaseback refunds previously made to customers. SERI is an Entergy subsidiary that is the majority owner of the Grand Gulf Nuclear Station in Port Gibson, Miss. Ultimately, the IRS allowed over $100M of the tax positions taken and the subsequent credits were passed on directly to customers. FERC's order does not require any further refunds or credits beyond those previously paid. Entergy Mississippi reached a settlement agreement with the Mississippi Public Service Commission in summer 2022 on a number of pending SERI cases being litigated, including the case resolved today by the FERC. That agreement provided $300M in credits directly to Entergy Mississippi customers.

07:24 EDT Catalent establishes committee to conduct review, enters pact with Elliot - Catalent announced several initiatives. The Nominating and Corporate Governance Committee of the board has recommended, and the board has approved, the appointment of four new independent directors: Steven Barg, Frank D'Amelio, Stephanie Okey, and Michelle Ryan. With these appointments, Catalent's board of directors will consist of 16 directors, 13 of whom are independent under the company's director independence standards. It is expected that the 12 nominees recommended by the board in the company's proxy statement and on its proxy card to stand for election at the 2023 Annual Meeting of Stockholders will include the four new directors and eight other nominees, who are current directors, to be selected by the board. In addition, John Greisch has been appointed executive chair of the board and will also chair the new Strategic and Operational Review Committee, as discussed further below. Catalent's board has also established a new Strategic and Operational Review Committee to conduct a review of the company's business, strategy and operations, as well as the Company's capital-allocation priorities, in order to maximize the long-term value of the company. The Strategic and Operational Review Committee will be chaired by Greisch and will include Barg, Ryan, Gregory Lucier and Jack Stahl. The committee will make its recommendations to the full board. In connection with these initiatives, Catalent has entered into a cooperation agreement with Elliott Investment Management L.P., one of Catalent's largest investors, under which Elliott has agreed to customary standstill, voting, confidentiality, and other provisions.

07:20 EDT Catalent adding four new independent directors as part of pact with Elliott

07:19 EDT Catalent established board committee to review business, strategy and operations

07:15 EDT Charge Enterprises announces CEO Andrew Fox resigns, Craig Denson named interim - Charge Enterprises announced that the Board of Directors of the Company has appointed Craig Denson, Charge's current Chief Operating and Compliance Officer, as Interim Chief Executive Officer, effective August 31. This appointment follows Andrew Fox's decision, made with the Board's agreement, to resign from his role as CEO and Chairman of the Board. In conjunction with this strategic decision, Amy Hanson, current Chair of the Audit Committee and Lead Independent Director, will assume the responsibilities of Chairperson. Mr. Fox will continue to serve as a director on the Board and will also serve as a strategic advisor to the Board, drawing upon his history with the Company and experience in the industry. "On behalf of the entire Board, we extend our gratitude to Mr. Fox for his pivotal role in setting the groundwork that forms the foundation of our Company. We look forward to continuing to benefit from his entrepreneurial vision and passion in the electric vehicle charging infrastructure space," said Amy Hanson. "Leading Charge Enterprises has been a privilege, and I am proud of everything we have built. The Company's forward momentum is paramount to me, and I believe Craig, given his operational and public company management experience, is exactly the type of executive to lead Charge during this interim period as we look to capitalize on the tremendous opportunities that lie ahead," said Andrew Fox.

07:12 EDT Omega Therapeutics announces updates to its board of directors - Omega Therapeutics announced that Chris Schade has been appointed as Chairman of the Board, succeeding Noubar Afeyan, Ph.D. In addition, Michelle Werner will join Omega's Board to support the Company's growth.Werner currently serves as the CEO of Alltrna and CEO-Partner at Flagship Pioneering.

07:11 EDT Laser Photonics: Canadian fabrication company orders MarkStar Pro - Laser Photonics announced it received an order from a Canada-based fabrication company for its MarkStar Pro LPC-MS-PRO. "Our MarkStar Pro laser marking system provided the perfect solution to this company's unique challenge," commented Wayne Tupuola, CEO of Laser Photonics. "The company was in search of an effective method of marking cylinder-shaped products, and our MarkStar system blew expectations out of the water when paired with our pipe adapter." A large machining and fabrication company based in Canada has adopted the MarkStar Pro to dependably and effectively mark parts to streamline their operations. The company turned to Laser Photonics as a trusted supplier of laser marking technology due to their cutting-edge products being able to reliably mark curved surfaces while remaining cost-effective and time-efficient. This system excels at making permanent, durable, and high-contrast marks on a variety of surfaces and materials.

07:10 EDT Marqeta appoints Heather Gantt-Evans as chief information security officer - Marqeta announced the appointment of Heather Gantt-Evans as its chief information security officer, or CISO. Gantt-Evans is a previous security and risk management leader at SailPoint and will be responsible for overseeing Marqeta's global corporate and product security strategies.

07:09 EDT TScan announces FDA clearance of IND application for TSC-203-A0201 - TScan Therapeutics announced that the U.S. Food and Drug Administration, FDA, has cleared its investigational new drug, IND, application for TSC-203-A0201, a TCR-T targeting PReferentially expressed Antigen in Melanoma, PRAME. In addition to being expressed in ~90% of melanomas, PRAME is also frequently expressed in various other solid tumors, including ~90% of head & neck cancers and ~50% of non-small cell lung cancers. TSC-203-A0201 is specific for patients with HLA type A*02:01, which represents over 40% of people in the U.S. TSC-203-A0201 is the fourth TCR-T cleared for clinical development in the Company's solid tumor program, following TSC-200-A0201, TSC-204-A0201, and TSC-204-C0702, which target human papillomavirus 16 presented on HLA type A*02:01, and MAGE-A1 presented on HLA types A*02:01 and C*07:02, respectively. All four TCR-T cell products are designed to be used in combination with each other and are being developed under a single master clinical trial protocol. "TScan continues to make great progress towards our vision of delivering enhanced, multiplexed TCR-Ts to a broad patient population," said Gavin MacBeath, Ph.D., Chief Executive Officer. "The IND clearance of TSC-203-A0201, the fourth TCR-T cell product cleared for our T-Plex solid tumor program, highlights the strength of our discovery platform and the potential of cell therapy to treat patients with a wide variety of solid tumors. PRAME is a particularly important target, as it is very frequently expressed in solid tumors and recent clinical trials targeting PRAME have shown promising results. In parallel, we are increasing our discovery efforts to further expand the number of therapeutic TCRs suitable for clinical development, and we anticipate additional IND filings for our solid tumor program this year and next."

07:08 EDT Nayax enters strategic partnership with Giift for loyalty solution - Nayax nnounced a strategic partnership with Giift. This collaboration introduces the open-loop Loyalty to Payment solution, powered via CoinBridge by Nayax's patented technology. This pioneering solution allows for seamless conversion of any loyalty asset, such as points, rewards, miles, vouchers, and gift-cards, into transactions, at any shop or merchant anywhere in the world, without the need for any merchant integrations or cross-brand partnerships.

07:06 EDT Xortx Therapeutics submits ODD application to EMA for treating APKD - XORTX Therapeutics announces that it has submitted an Orphan Drug Designation, ODD, application for XORLO to the European Medicines Agency, EMA. The "orphan-drug designation request is for the use of XORTX's patented unique proprietary formulation of oxypurinol - XORLO- for the treatment of autosomal dominant polycystic kidney disease, APKD". Dr. Allen Davidoff, CEO of XORTX, stated, "This EMA ODD submission represents a key milestone for the Company regarding new and existing discoveries made by XORTX and its novel approach to slowing progression of kidney disease in ADPKD. It also follows on receipt of ODD status granted by the U.S. Food and Drug Administration in April 2023. Further updates will be provided once the EMA COMP renders its decision."

07:05 EDT Apellis announces restructuring including 25% workforce reduction - Apellis announced a corporate restructuring to drive growth of Syfovre pegcetacoplan injection and Empaveli. This restructuring will include cost reduction initiatives expected to result in up to $300M in total cost savings through 2024. The company remains focused on supporting the continued U.S. commercial launch of SYFOVRE and is preparing for potential ex-U.S. launches, with an anticipated decision on regulatory approval by the EMA in early 2024. In the first half of 2023, Syfovre generated $85.7M in U.S. net product revenues. The company is preparing to launch Syfovre in the EU, prioritizing an initial launch in Germany. Marketing applications for intravitreal pegcetacoplan are also under review in Canada, Australia, the U.K. and Switzerland, with decisions expected in the first half of 2024. Reducing Empaveli-related expenses. In the first half of 2023, Empaveli generated $42.7M in U.S. net product revenues. The ompany does not plan to initiate any new clinical development programs with systemic pegcetacoplan. Intends to focus research initiatives on high-potential opportunities in retina and central nervous system diseases, and deprioritizing certain development initiatives. Reducing headcount by approximately 225 employees, or approximately 25% of the current workforce across the organization. Field-based commercial and medical employees are minimally affected. The planned workforce reduction is anticipated to be substantially completed in Q3. Apellis expects these actions to result in total cost savings of up to $300M through 2024, which includes more than $70M in expected net cost savings related to the workforce reduction and up to $230M related to the elimination of planned external expenses. Apellis expects to incur one-time costs related to the workforce reduction of $9M-$11M, substantially all of which are cash expenditures. These costs are anticipated to be incurred primarily in the second half of 2023.

07:04 EDT Big Lots sees Q3 SSS 'down in the low-teen range' - For the third quarter, the company expects comps to be down in the low-teen range, modestly improved relative to the second quarter. A net decrease in store count, partially offset by new stores and relocations, will contribute approximately 140 basis points of sales decline compared to the third quarter of 2022. With regard to gross margin rate, the company expects accelerated rate improvement in the second half of the year, with approximately 200 basis points of improvement in the third quarter relative to the prior year quarter. The company expects adjusted SG&A dollars to be down by a low-single digit percentage versus 2022. The company does not expect to recognize any tax benefit in the third quarter as we expect to remain in a three-year cumulative loss position, which requires us to record valuation allowances against deferred tax assets, including those related to net operating losses. The company is not providing EPS guidance at this point. The company expects a share count of approximately 29.3 million for the third quarter. For the fourth quarter, the company expects comp sales to be improved relative to the third quarter and be in the high-single-digit negative range, as key actions to improve the business continue to gain traction. The company expects the fourth quarter gross margin rate to improve to a rate into the high-30s range driven by more normalized markdown activity, lower freight costs, and cost reduction and productivity initiatives.

06:57 EDT NRx Pharmaceuticals to purchase 3M shares of preferred stock at 40c per share - NRx Pharmaceuticals announced that it entered into a definitive purchase agreement subject to standard closing conditions with accredited investors to purchase 3M shares of preferred stock at 40c per share, which will convert, after six months into 3M common shares and 3M warrants to purchase common stock at a purchase price of 40c per share; the term on these warrants is five years. These shares may also be converted to common shares at the investor's option should the closing share price of NRx common stock reach $1.20 per share during the six-month period.

06:54 EDT Piedmont Lithium gets partial prepayment for shipment of lithium concentrate - Piedmont Lithium announced receipt of a $31.6M partial prepayment for the sale of 15,000 dry metric tons of 5.4% Li2O lithium concentrate on an FOB vessel basis to a major international trading company. Vessel loading is scheduled for mid-September. The prepayment increased Piedmont's cash position to approximately $100M, reinforcing Piedmont's strong balance sheet. North American Lithium commenced commercial production in March 2023 and delivered its first joint venture shipment of 20,500 dmt to a third-party in early August. Production ramp up continues to progress well, and Piedmont expects to receive, at a minimum, its full 2023 offtake allocation of 56,500 dmt of lithium concentrate, with the balance to be sold by the joint venture.

06:51 EDT Merck: EC approves Keytruda in combination with trastuzumab - Merck announced that the European Commission has approved KEYTRUDA, Merck's anti-PD-1 therapy, in combination with trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy, for the first-line treatment of locally advanced unresectable or metastatic human epidermal growth factor receptor 2-positive gastric or gastroesophageal junction adenocarcinoma in adults whose tumors express PD-L1. This approval allows marketing of this KEYTRUDA regimen in all 27 European Union member states plus Iceland, Lichtenstein, Norway and Northern Ireland.

06:48 EDT Castellum subsidiary awarded $3M U.S. Navy contract - Castellum announces that its Specialty Systems subsidiary has been awarded a $3M, 14-month U.S. Navy contract. With this contract, Castellum furthers the commitment to its U.S. Navy mission.

06:43 EDT PDD Holdings jumps 13% to $91.30 after Q2 results beat estimates

06:39 EDT NexGen Energy CFO Harpreet Dhaliwal resigns, Ben Salter succeeds - NexGen Energy announced the appointment of Ben Salter as CFO, effective September 1. Salter commenced with NexGen in June 2021 and currently holds the role of VP, finance. Prior to NexGen, Salter worked at Methanex Corporation and Innergex Renewable Energy Inc. where he was responsible for financial reporting, controls and systems. Salter will assume the CFO position upon the resignation of Harpreet Dhaliwal who is pursuing other career interests.

06:36 EDT 3M to record pre-tax charge of $4.2B in Q3 - As a result of the agreement, the company will record a pre-tax charge of approximately $4.2B in the third quarter, representing the $5.3B pre-tax present value of contributions under the agreement net of 3M's existing accrual of approximately $1.1B related to this matter. This charge will be reflected as an adjustment in arriving at 3M's results, adjusted for special items. Additional details of the agreement, including the anticipated payment schedules provided that certain conditions are met, will be included in 3M's filings with the Securities and Exchange Commission. Aearo and 3M are actively engaged in insurance recovery activities to offset a portion of the settlement payments, and Aearo initiated insurance recovery litigation against its carriers in June related to the litigation.

06:34 EDT 3M announces $6B combat arms settlement - 3M announced that it has reached an agreement with the court-appointed negotiating plaintiffs' counsel to resolve the Combat Arms Earplug litigation against Aearo Technologies and 3M. Under the agreement, 3M will contribute a total amount of $6B between 2023 and 2029, which is structured under the agreement to include $5B in cash and $1B in 3M common stock. This agreement, reached through the mediation process that 3M has previously disclosed, is structured to promote participation by claimants and is intended to resolve all claims associated with the Combat Arms Earplug products. The agreement includes all claims in the multi-district litigation in Florida and in the coordinated state court action in Minnesota, as well as potential future claims. The Florida and Minnesota courts are entering orders to support implementation of the agreement. This agreement is not an admission of liability. The products at issue in this litigation are safe and effective when used properly. 3M is prepared to continue to defend itself in the litigation if certain agreed terms of the settlement agreement are not fulfilled.

06:29 EDT Nano Dimension: ISS urges shareholders to vote for Nano's directors - Proxy advisor Institutional Shareholder Services recommends Nano Dimension's shareholders vote for Nano's directors and against Murchinson nominees.

06:15 EDT Cruise begins testing robotaxis in Seattle, Washington D.C. - General Motors' self-driving subsidiary Cruise posted a Monday tweet, which read, "We're thrilled to begin our manual data collection in both Seattle and Washington, D.C. this week. Stay tuned for more updates soon." Reference Link

06:05 EDT Shell announces Executive Committee change - Ronan Cassidy, Shell plc's Chief Human Resources and Corporate Officer, will step down with effect from December 31, 2023, and leave Group service thereafter. Rachel Solway, currently Executive Vice President, Human Resources Organisation Development & Learning, will succeed Ronan with effect from January 1, 2024 and will be based in London. Shell CEO Wael Sawan said: "I'd like to thank Ronan for his 35 years of distinguished service to Shell. In his eight years on the Executive Committee, Ronan has helped steer us through transformational change and several exceptional events, including the Covid-19 pandemic, with wisdom, integrity and foresight. He has championed employee engagement, ethical leadership and diversity, equity, and inclusion, and will leave having helped change Shell for the better."

06:04 EDT Roche reports EC approves Evrysdi for babies under two months old with SMA - Roche announced that the European Commission has approved the extension of the Evrysdi European Union marketing authorization to include infants with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 or with one to four SMN2 copies from birth to below two months. Interim data from the ongoing RAINBOWFISH trial in pre-symptomatic babies from birth to six weeks with Type 1 SMA supported the marketing authorization extension, the company stated.

05:39 EDT Accenture acquires ATI Solutions Group, terms undisclosed - Accenture has acquired ATI Solutions Group, or ATI, a Perth-based consulting service provider to the mining, energy and rail industries. ATI will enhance Accenture's capabilities in West Australia, where specialized digital and industrial talent is in high demand. Terms of the transaction were not disclosed.

05:30 EDT CAE secures 10-year pilot training agreement with Batik Air - CAE announced at the Asia Pacific Airline Training Symposium, or APATS, that it has secured a 10-year pilot training agreement with Batik Air. CAE will deploy and operate an advanced B737 MAX full-flight simulator at Batik Air's facility in Kuala Lumpur, ensuring a world-class training experience for the airline's pilots. In addition, Batik Air will adopt the use of CAE Rise, CAE's data-driven training system which leverages advanced analytics to deliver more effective training and enhance operational safety.

05:22 EDT Kaival Brands adds over 1,500 locations to its Bidi Stick Circle K rollout - Kaival Brands provided an update on its efforts to increase distribution of the Bidi Stick which have resulted in distribution in more than 1,500 additional Circle K locations. Eric Mosser, CEO of Kaival Brands, stated, "We are excited to provide an update on our regional Circle K rollout. Since our initial rollout in June, we have increased distribution to over 2,700 locations from just over 1,000. Our objective is that ultimately, the BIDI(R) Stick will be distributed in up to 5,000 Circle K locations within the South Atlantic and Midwest regions within the calendar year." Mr. Mosser continues, "We are as optimistic as ever that our ongoing efforts will continue to open doors with retail partners like Circle K who share our commitment to compliance and youth-access prevention, and, in turn, increase our revenues going forward."

05:16 EDT Sinovac Biotech confirms receipt of unsolicited partial tender offer - Sinovac Biotech confirmed that it is aware of an unsolicited partial tender offer from Alternative Liquidity Index LP to purchase up to a maximum of 10M shares of the company, representing approximately 10.05% of the company's outstanding shares, for 3c per share in cash. Sinovac's board of directors intends to evaluate the terms of the tender offer to determine the course of action that it believes is in the best interest of the company and its shareholders. The board also intends to advise shareholders of the board's position regarding the tender offer within ten business days of receipt of the offer. In the meantime, the company's shareholders are strongly advised to take no action in relation to the tender offer.